Clinical Trial Update: New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) [Phase 3]

View source ↗

Summary

Pfizer conducted a Phase 3 trial in pediatric patients for a new antibiotic addressing infections caused by vancomycin-resistant Enterococcus; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vancomycin-resistant Enterococcus Infection

Snippet

Sponsor: Pfizer | Conditions: Bacterial Infections | Phase 3 | Status: COMPLETED